Cancer Incidence and Mortality among Non-Hispanics, New York City, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 32668.6 467.7 465.4-470.0 15711.0 512.1 508.4-515.7 16957.6 441.3 438.3-444.4 10459.0 146.4 145.1-147.6 5088.8 171.9 169.8-174.1 5370.2 129.8 128.2-131.4
Oral cavity and pharynx 713.2 10.2 9.9-10.6 468.4 15.0 14.4-15.7 244.8 6.3 6.0-6.7 164.6 2.3 2.2-2.5 112.4 3.6 3.3-4.0 52.2 1.3 1.1-1.5
Esophagus 259.0 3.6 3.4-3.8 183.2 5.9 5.6-6.4 75.8 1.8 1.6-2.0 191.8 2.7 2.5-2.9 135.2 4.5 4.1-4.8 56.6 1.3 1.2-1.5
Stomach 769.6 10.9 10.6-11.3 453.0 15.0 14.4-15.7 316.6 7.9 7.5-8.3 357.2 5.0 4.8-5.3 215.2 7.3 6.8-7.7 142.0 3.4 3.1-3.6
Colorectal 2833.0 40.4 39.7-41.1 1425.4 47.2 46.1-48.4 1407.6 35.3 34.4-36.1 1018.0 14.1 13.7-14.5 489.4 16.5 15.9-17.2 528.6 12.3 11.9-12.8
Colon excluding rectum 2017.6 28.7 28.1-29.3 975.8 32.6 31.7-33.6 1041.8 25.9 25.2-26.6 844.0 11.7 11.3-12.0 395.8 13.4 12.8-14.0 448.2 10.4 10.0-10.9
Rectum & rectosigmoid 815.4 11.7 11.3-12.1 449.6 14.6 14.0-15.2 365.8 9.4 9.0-9.9 174.0 2.4 2.3-2.6 93.6 3.1 2.8-3.4 80.4 1.9 1.7-2.1
Liver / intrahepatic bile duct 753.0 10.4 10.0-10.7 531.8 16.5 15.9-17.1 221.2 5.4 5.1-5.8 481.2 6.7 6.4-6.9 328.6 10.5 10.0-11.0 152.6 3.7 3.4-3.9
Pancreas 1004.2 14.0 13.6-14.4 481.4 15.9 15.2-16.5 522.8 12.6 12.1-13.1 803.2 11.2 10.8-11.5 383.0 12.7 12.1-13.3 420.2 10.0 9.5-10.4
Larynx 211.8 3.0 2.8-3.1 173.4 5.6 5.2-6.0 38.4 1.0 0.8-1.1 70.6 1.0 0.9-1.1 55.6 1.8 1.6-2.1 15.0 0.4 0.3-0.4
Lung and bronchus 3648.2 51.4 50.7-52.2 1822.8 60.6 59.3-61.8 1825.4 45.1 44.2-46.1 2270.6 31.8 31.2-32.4 1210.4 40.7 39.6-41.7 1060.2 25.6 24.9-26.3
Melanoma of the skin 870.6 12.6 12.2-12.9 476.8 16.0 15.4-16.7 393.8 10.2 9.7-10.7 100.8 1.4 1.3-1.5 59.4 2.0 1.8-2.2 41.4 1.0 0.9-1.1
Female breast             4833.4 129.7 128.0-131.4             868.6 21.5 20.9-22.2
Cervix uteri             317.0 9.0 8.5-9.5             102.6 2.7 2.5-3.0
Corpus uterus and NOS             1300.8 32.8 32.0-33.7             298.6 7.2 6.9-7.6
Ovary             466.4 12.3 11.8-12.8             292.0 7.3 6.9-7.7
Prostate       4130.2 128.1 126.3-129.9             564.2 20.0 19.3-20.8      
Testis       155.2 5.1 4.7-5.4             4.8 0.2 0.1-0.2      
Urinary bladder (incl. in situ) 1299.8 18.3 17.9-18.8 961.8 32.8 31.9-33.8 338.0 8.1 7.7-8.5 283.0 3.8 3.6-4.1 190.4 6.7 6.3-7.1 92.6 2.0 1.8-2.2
Kidney and renal pelvis 1031.2 14.8 14.4-15.2 664.0 21.4 20.6-22.1 367.2 9.5 9.1-10.0 189.4 2.6 2.5-2.8 120.0 4.0 3.7-4.4 69.4 1.6 1.5-1.8
Brain and other central nervous system 403.4 6.2 5.9-6.5 217.6 7.4 6.9-7.8 185.8 5.3 4.9-5.6 223.8 3.2 3.0-3.4 115.2 3.8 3.5-4.1 108.6 2.8 2.6-3.0
Thyroid 1495.4 22.9 22.4-23.5 368.8 12.0 11.5-12.6 1126.6 32.7 31.8-33.6 42.6 0.6 0.5-0.7 16.6 0.5 0.4-0.7 26.0 0.6 0.5-0.7
Hodgkin lymphoma 204.2 3.3 3.0-3.5 104.2 3.5 3.2-3.9 100.0 3.0 2.7-3.3 20.6 0.3 0.2-0.4 10.8 0.4 0.3-0.5 9.8 0.3 0.2-0.3
Non-Hodgkin lymphomas 1412.8 20.5 20.0-21.0 753.2 25.1 24.3-26.0 659.6 16.9 16.3-17.5 357.6 5.0 4.8-5.3 189.6 6.5 6.1-6.9 168.0 4.0 3.7-4.3
Myeloma 636.0 9.0 8.7-9.3 335.6 11.0 10.5-11.6 300.4 7.5 7.1-7.9 222.0 3.1 2.9-3.3 116.6 3.9 3.6-4.3 105.4 2.5 2.3-2.8
Leukemias 1010.8 14.8 14.4-15.2 565.8 19.2 18.5-19.9 445.0 11.6 11.1-12.1 412.2 5.9 5.7-6.2 229.2 8.0 7.5-8.4 183.0 4.5 4.2-4.8

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.